The psychedelics industry received a boost in confidence this week by way of a new market report from banking giant Morgan Stanley.
Morgan Stanley (NYSE:MS) has shared its first official commentary on the psychedelics industry.
The concept of investing in psychedelic medicine received a legitimate vote of confidence of sorts after the well-established banking firm released an introductory study evaluating the potential attached to the sector.
https://investingnews.com/morgan-stanley-first-psychedelics-research/
Ann: Preclinical studies initiated for MDMA-inspired analogues, page-6
Add to My Watchlist
What is My Watchlist?
